Clinical trial
An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling
NCT00273702 · University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00273702 |
|---|---|
| Title | An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling |
| Official title | An Open-Label Study of N-Acetyl Cysteine in Pathological Gambling |
| Lead sponsor | University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pathological Gambling |
| Intervention type | Drug |
| Interventions | N-Acetyl Cysteine |
| Enrollment | 36 |
| Start date | Jan 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jan 9, 2006 |
| Last update posted | Apr 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: